Ambry Genetics offers the Affymetrix Drug-Metabolizing Enzymes and Transporters (DMET) drug metabolism panel service consisting of 1,936 markers in 225 genes.  The DMET panel features markers in all FDA-validated genes and covers more than 90 percent of the current ADME Core markers as defined by the Pharma ADME group.   This service can be performed for research or regulated use. Our team of experts is always available to assist you with your project needs.